Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Could the Addition of Cetuximab to Conventional Radiation Therapy Improve Organ Preservation in Those Patients With Locally Advanced Larynx Cancer Who Respond to Induction Chemotherapy? An Organ Preservation Spanish Head and Neck Cancer Cooperative Group Phase 2 Study.
Mesía R, Garcia-Saenz JA, Lozano A, Pastor M, Grau JJ, Martínez-Trufero J, Lambeaz J, Martínez-Galán J, Mel JR, González B, Vázquez S, Mañós M, Taberna M, Cirauqui B, Del Barco E, Casado E, Rubió-Casadevall J, Rodríguez-Jaráiz A, Cruz JJ; Spanish Head And Neck Cancer Cooperative Group (Study TTCC-2007/02). Mesía R, et al. Among authors: rodriguez jaraiz a. Int J Radiat Oncol Biol Phys. 2017 Mar 1;97(3):473-480. doi: 10.1016/j.ijrobp.2016.11.016. Epub 2016 Nov 17. Int J Radiat Oncol Biol Phys. 2017. PMID: 28011050 Clinical Trial.
A randomized phase III trial comparing induction chemotherapy followed by chemoradiotherapy versus chemoradiotherapy alone as treatment of unresectable head and neck cancer.
Hitt R, Grau JJ, López-Pousa A, Berrocal A, García-Girón C, Irigoyen A, Sastre J, Martínez-Trufero J, Brandariz Castelo JA, Verger E, Cruz-Hernández JJ; Spanish Head and Neck Cancer Cooperative Group (TTCC). Hitt R, et al. Ann Oncol. 2014 Jan;25(1):216-25. doi: 10.1093/annonc/mdt461. Epub 2013 Nov 19. Ann Oncol. 2014. PMID: 24256848 Free article. Clinical Trial.
Combination therapy with docetaxel and low dose of cisplatin in elderly patients with advanced non-small cell lung cancer: multicenter phase II study.
Feliu J, Firvida JL, Castro J, Madroñal C, Rodríguez-Jaráiz A, Salgado M, Belda-Iniesta C, Casado E, García-Mata J, González-Barón M; Oncopaz Cooperative Group. Feliu J, et al. Among authors: rodriguez jaraiz a. Cancer Chemother Pharmacol. 2009 Feb;63(3):403-9. doi: 10.1007/s00280-008-0749-z. Epub 2008 Apr 9. Cancer Chemother Pharmacol. 2009. PMID: 18398610 Clinical Trial.
Docetaxel and mitomycin as second-line treatment in advanced non-small cell lung cancer.
Feliu J, Martín G, Castro J, Sundlov A, Rodriguez-Jaráiz A, Casado E, Lomas M, Madroñal C, Galán A, Belda C, Gonzalez-Barón M. Feliu J, et al. Among authors: rodriguez jaraiz a. Cancer Chemother Pharmacol. 2006 Oct;58(4):527-31. doi: 10.1007/s00280-006-0198-5. Epub 2006 Mar 23. Cancer Chemother Pharmacol. 2006. PMID: 16555090 Clinical Trial.
Combination of low-dose cisplatin and gemcitabine for treatment of elderly patients with advanced non-small-cell lung cancer.
Feliu J, Martín G, Madroñal C, Rodríguez-Jaráiz A, Castro J, Rodríguez A, Checa T, Bolaño M, Casado E, González-Barón M. Feliu J, et al. Among authors: rodriguez jaraiz a. Cancer Chemother Pharmacol. 2003 Sep;52(3):247-52. doi: 10.1007/s00280-003-0638-4. Epub 2003 May 29. Cancer Chemother Pharmacol. 2003. PMID: 12783203 Clinical Trial.